UY29227A1 - SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG - Google Patents
SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUGInfo
- Publication number
- UY29227A1 UY29227A1 UY29227A UY29227A UY29227A1 UY 29227 A1 UY29227 A1 UY 29227A1 UY 29227 A UY29227 A UY 29227A UY 29227 A UY29227 A UY 29227A UY 29227 A1 UY29227 A1 UY 29227A1
- Authority
- UY
- Uruguay
- Prior art keywords
- drospirenone
- dissolution
- pharmaceutical composition
- speed
- combination
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con una composición farmacéutica asegurando una velocidad de disolución y homogenización de la droga no micronizada logrando una estabilidad físico-química inesperada.También con la composición farmacéutica obtenida por ese proceso y el uso de la composición farmacéutica para preparar un medicamento. La composición farmacéutica comprende, una combinación de dos principios activos, a saber drospirenona y etinilestradiol, un agente surfactante y excipientes farmacéuticamente aceptables con la condición de que la drospirenona presente la siguiente distribución: aproximadamente el 95% de ellos presenten un tamano de partícula inferior a 100 um (micrómetros), aproximadamente el 26 % presente un tamano de partícula inferior a 20 um (micrómetros) y aproximadamente el 15% presente un tamano de partícula inferior a 10.00 um (micrómetros), o con la condición de que dichos principios activos presenten una área superficial menos a 10000cm2/g o con la condición que la drospirenona no se encuentra en forma micronizada. Esta composición es usada para inhibir la ovulación y los cambios en la secreción cervical.The present invention relates to a pharmaceutical composition ensuring a speed of dissolution and homogenization of the non-micronized drug achieving an unexpected physical-chemical stability. Also with the pharmaceutical composition obtained by that process and the use of the pharmaceutical composition to prepare a medicament. The pharmaceutical composition comprises, a combination of two active ingredients, namely drospirenone and ethinyl estradiol, a pharmaceutically acceptable surfactant and excipients with the proviso that drospirenone has the following distribution: approximately 95% of them have a particle size of less than 100 um (micrometers), approximately 26% have a particle size of less than 20 um (micrometers) and approximately 15% have a particle size of less than 10.00 um (micrometers), or with the condition that said active substances have a surface area less than 10000cm2 / g with the condition that drospirenone is not in a micronized form. This composition is used to inhibit ovulation and changes in cervical secretion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP040104928 AR047782A1 (en) | 2004-12-28 | 2004-12-28 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29227A1 true UY29227A1 (en) | 2005-12-30 |
Family
ID=36607162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29227A UY29227A1 (en) | 2004-12-28 | 2005-11-24 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR047782A1 (en) |
CO (1) | CO5770093A1 (en) |
PE (1) | PE20061112A1 (en) |
UY (1) | UY29227A1 (en) |
-
2004
- 2004-12-28 AR ARP040104928 patent/AR047782A1/en unknown
-
2005
- 2005-11-24 UY UY29227A patent/UY29227A1/en not_active Application Discontinuation
- 2005-12-27 CO CO05130115A patent/CO5770093A1/en not_active Application Discontinuation
-
2006
- 2006-01-03 PE PE2006000018A patent/PE20061112A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20061112A1 (en) | 2006-11-27 |
AR047782A1 (en) | 2006-02-22 |
CO5770093A1 (en) | 2007-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010339867B2 (en) | Nestorone/estradiol transdermal gel | |
MEP38008A (en) | Drospirenone for hormone replacement therapy | |
MA26843A1 (en) | NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT | |
BR9911073A (en) | Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute asthma condition | |
WO2004105694A3 (en) | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs | |
AR056609A1 (en) | STABILIZED COMPOSITIONS OF LANTAN CARBONATE | |
TW200514560A (en) | Pharmaceutical formulation for contraception and hormone-replacement therapy | |
AR034900A1 (en) | USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT | |
KR102433001B1 (en) | Usage and Dosage of Endometriosis Treatment | |
BR0210595A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
BR0114665A (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
BR0309057A (en) | Low dosage liquid formulations in entecavir and use | |
AR036970A1 (en) | ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION | |
CO5241355A1 (en) | PACKAGED FORM OF ACTIVE NUCLEOSIDIC PHARMACEUTICAL COMPOSITIONS FOR VACCINES AGAINST HEPATITIS | |
UY29227A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG | |
AR063111A1 (en) | A PHARMACEUTICAL FORMULATION OF TAXANO | |
BR0006556A (en) | Pharmaceutical composition for topical use of corticosteroids for the treatment of phimosis | |
AR044450A1 (en) | COMPOSITION THAT INCLUDES ANTAGONISTS OF PROGESTERONE RECEPTORS AND PURE ANTIESTROGENS FOR THE PROPHYLAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES | |
DOP2005000278A (en) | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENON, ETHYLINESTRADIOL AND A SUITABLE SURFACTANT AGENT THAT PRESENT A HOMOGENEITY OF CONTAINED SPEED AND SPEED OF DRUG FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION FOR COMPOSITION PREPARATION. | |
MA33808B1 (en) | SUSPENDED, SUSTAINED, LOW AND ULTRA LOW SUSPENSION PHARMACEUTICAL FORMULATION FOR USE IN MENOPAUSIC SYNDROME HORMONE THERAPY | |
BR112022023635A2 (en) | DRUG RELEASE SYSTEM FOR OPHTHALMIC USE | |
AR043470A2 (en) | A PHARMACEUTICAL COMPOSITION TO BE USED AS AN CONTRACEPTIVE | |
Sitruk-Ware et al. | Patent: Nestorone®/estradiol transdermal gel | |
BR0312003A (en) | Metastable pharmaceutical compositions for transdermal delivery and their uses | |
AR026747A1 (en) | EPERENONA CRYSTAL FORM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160726 |